Search research articles
Contact Us
Filters
Showing results (31-40 of 253) with videos related to
Page
of 26
Sort By:
Translational Andrology and Urology
|
September 15, 2025
Harnessing the power of combination therapy: reflecting on the final survival data from the CLEAR study with lenvatinib plus pembrolizumab
Brian M Shinder, Lingbin Meng, Eric A Singer
Current Opinion in Urology
|
August 2, 2008
Healthcare economics of bladder cancer: cost-enhancing and cost-reducing factors
Katia Noyes, Eric A Singer, Edward M Messing
Medical Research Archives
|
June 26, 2020
To Be or "Node" to Be: Nodal Disease and the Role of Lymphadenectomy in the Treatment of Renal Cell Carcinoma
Hiren V Patel, Arnav Srivastava, Eric A Singer
Frontiers in Oncology
|
July 26, 2022
Editorial: Biomarkers in Genitourinary Cancers, Volume I
Paula Alexandra Videira, Marco Borghesi, Eric A Singer
Current Opinion in Oncology
|
February 19, 2011
Update on targeted therapies for clear cell renal cell carcinoma
Eric A Singer, Gopal N Gupta, Ramaprasad Srinivasan
Urology Practice
|
May 5, 2023
Editorial Commentary
Kevin J Chua, Mark Mikhail, Eric A Singer
Current Opinion in Oncology
|
March 3, 2017
Renal cell carcinoma: molecular characterization and evolving treatment paradigms
Mark W Ball, Eric A Singer, Ramaprasad Srinivasan
Current Opinion in Oncology
|
February 21, 2012
Targeted therapeutic strategies for the management of renal cell carcinoma
Eric A Singer, Gopal N Gupta, Ramaprasad Srinivasan
Chest
|
October 13, 2018
Implications of the Revised Common Rule for Human Participant Research
Evan G DeRenzo, Joel Moss, Eric A Singer
Translational Cancer Research
|
August 20, 2016
Precision Oncology: Identifying Predictive Biomarkers for the Treatment of Metastatic Renal Cell Carcinoma
Parth K Modi, Nicholas J Farber, Eric A Singer
Page
of 26
Search research articles
Search
Showing results (31-40 of 253) with videos related to
Sort By:
Page
of 26
Translational Andrology and Urology
|
September 15, 2025
Harnessing the power of combination therapy: reflecting on the final survival data from the CLEAR study with lenvatinib plus pembrolizumab
Brian M Shinder, Lingbin Meng, Eric A Singer
Current Opinion in Urology
|
August 2, 2008
Healthcare economics of bladder cancer: cost-enhancing and cost-reducing factors
Katia Noyes, Eric A Singer, Edward M Messing
Medical Research Archives
|
June 26, 2020
To Be or "Node" to Be: Nodal Disease and the Role of Lymphadenectomy in the Treatment of Renal Cell Carcinoma
Hiren V Patel, Arnav Srivastava, Eric A Singer
Frontiers in Oncology
|
July 26, 2022
Editorial: Biomarkers in Genitourinary Cancers, Volume I
Paula Alexandra Videira, Marco Borghesi, Eric A Singer
Current Opinion in Oncology
|
February 19, 2011
Update on targeted therapies for clear cell renal cell carcinoma
Eric A Singer, Gopal N Gupta, Ramaprasad Srinivasan
Urology Practice
|
May 5, 2023
Editorial Commentary
Kevin J Chua, Mark Mikhail, Eric A Singer
Current Opinion in Oncology
|
March 3, 2017
Renal cell carcinoma: molecular characterization and evolving treatment paradigms
Mark W Ball, Eric A Singer, Ramaprasad Srinivasan
Current Opinion in Oncology
|
February 21, 2012
Targeted therapeutic strategies for the management of renal cell carcinoma
Eric A Singer, Gopal N Gupta, Ramaprasad Srinivasan
Chest
|
October 13, 2018
Implications of the Revised Common Rule for Human Participant Research
Evan G DeRenzo, Joel Moss, Eric A Singer
Translational Cancer Research
|
August 20, 2016
Precision Oncology: Identifying Predictive Biomarkers for the Treatment of Metastatic Renal Cell Carcinoma
Parth K Modi, Nicholas J Farber, Eric A Singer
Page
of 26